课题基金 / 基金详情

Characterization of T-cell receptor sequence and signaling activity towards HIV-1 HLA-B*81- and HLA-B*42-restricted Gag TL9 epitope

Characterization of T-cell receptor sequence and signaling activity towards HIV-1 HLA-B*81- and HLA-B*42-restricted Gag TL9 epitope
T 细胞受体序列的表征以及针对 HIV-1 HLA-B*81 和 HLA-B*42 限制性 Gag TL9 表位的信号传导活性
批准号:
368285
负责人:
Anmole Gursev S
金额:
$0.11万
依托单位国家:
加拿大
项目类别:
财政年份:
2017
资助国家:
加拿大
项目状态:
已结题
起止时间:
2017-07-01 至 2018-07-01
关键词:

项目摘要

项目成果

Anmole Gursev S的其他基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
The development of highly active combination anti-retroviral therapy (cART) has transformed treatment outcomes for HIV infection, such that it is now a manageable chronic condition in Canada. However, HIV establishes latent reservoirs that persist for the
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Characterizing TCR function in HIV controllers: strategies for novel vaccines and immune based therapeutics
Construction of a Novel Chimeric T Cell Antigen Receptor That Targets HIV gp120 on Reactivating Cells
Identification of HIV-1 peptide mimotopes using a T cell receptor reporter assay